Ukraine: APRaD position on the CMU Draft Resolution

The Ukrainian pharmaceutical trade body the APRaD has issued a notice of its position on the Resolution of the Cabinet of Ministers of Ukraine (CMU) on some issues of state regulation of prices for medicines (the National List of Essential Medicines) in the context of improving patients' access to innovative medicines and necessary therapies.

Patients’ access to the necessary medicines is an important and multi-component issue which includes availability of the relevant mechanisms of social protection and public healthcare coverage (such as, for example, the system of reimbursement of the cost of medicines, compulsory state social health insurance etc.) and, therefore, the approach suggested by the Ministry of Health of Ukraine towards formation of the National List of Essential Medicines must be system-based and thoroughly coordinated.

In general, the APRaD supports the intentions of the Ministry of Health of Ukraine to form the National List on the basis of the universally acknowledged methodology suggested by the World Health Organization in May 2015 (the new edition of WHO Model List of Essential Medicinal Products), and with consideration of the effective and updatable documentation of the Ministry of Health on medical process control.